Device Orthodontics

Carriere Slx 3d

Payments companies reported to CMS as associated with Carriere Slx 3d. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$602Kassociated payments (2023-2025)
209clinicians with associated payments
1company reporting

By year

2023 $377K
2024 $113K
2025 $112K

Payments reported as associated with Carriere Slx 3d, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthodontics and Dentofacial Orthopedics $502K
Dentist $89K
General Practice (Dentist) $9,333
Pediatric Dentistry $115
Physician Assistant $82.95
Prosthodontics $16.80

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Carriere Slx 3d

These are the largest totals companies reported as associated with Carriere Slx 3d. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
David Paquette Charlotte, NC Orthodontics and Dentofacial Orthopedics $139,043.15
Ronald Risinger Beaumont, TX Orthodontics and Dentofacial Orthopedics $138,680.31
Michael Ragan Dallas, TX Orthodontics and Dentofacial Orthopedics $49,604.50
Mario Chorak Renton, WA Orthodontics and Dentofacial Orthopedics $45,942.03
Francisco Eraso Indianapolis, IN Dentist $36,223.85
David Ostreicher Levittown, NY Dentist $24,591.00
Andrew Ferris Santa Barbara, CA Orthodontics and Dentofacial Orthopedics $22,555.34
Anas Athar San Antonio, TX Orthodontics and Dentofacial Orthopedics $20,000.00
Melissa Shotell Sonora, CA Orthodontics and Dentofacial Orthopedics $15,786.69
James Paschal Madison, GA Orthodontics and Dentofacial Orthopedics $15,124.24

Prescribed Carriere Slx 3d?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.